- Home
- ONCY vs NIM Comparison
ONCY vs NIM Comparison
Compare ONCY & NIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- NIM
- Stock Information
- Founded
- ONCY 1998
- NIM 1992
- Country
- ONCY Canada
- NIM United States
- Employees
- ONCY N/A
- NIM N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- NIM Trusts Except Educational Religious and Charitable
- Sector
- ONCY Health Care
- NIM Finance
- Exchange
- ONCY Nasdaq
- NIM Nasdaq
- Market Cap
- ONCY 106.1M
- NIM 115.7M
- IPO Year
- ONCY 1999
- NIM N/A
- Fundamental
- Price
- ONCY $0.99
- NIM $9.32
- Analyst Decision
- ONCY Strong Buy
- NIM
- Analyst Count
- ONCY 6
- NIM 0
- Target Price
- ONCY $6.00
- NIM N/A
- AVG Volume (30 Days)
- ONCY 750.7K
- NIM 35.4K
- Earning Date
- ONCY 11-12-2025
- NIM 01-01-0001
- Dividend Yield
- ONCY N/A
- NIM 3.46%
- EPS Growth
- ONCY N/A
- NIM N/A
- EPS
- ONCY N/A
- NIM N/A
- Revenue
- ONCY N/A
- NIM N/A
- Revenue This Year
- ONCY N/A
- NIM N/A
- Revenue Next Year
- ONCY N/A
- NIM N/A
- P/E Ratio
- ONCY N/A
- NIM N/A
- Revenue Growth
- ONCY N/A
- NIM N/A
- 52 Week Low
- ONCY $0.33
- NIM $8.28
- 52 Week High
- ONCY $1.51
- NIM $9.74
- Technical
- Relative Strength Index (RSI)
- ONCY 39.40
- NIM 49.35
- Support Level
- ONCY $0.97
- NIM $9.23
- Resistance Level
- ONCY $1.05
- NIM $9.38
- Average True Range (ATR)
- ONCY 0.06
- NIM 0.10
- MACD
- ONCY 0.00
- NIM -0.02
- Stochastic Oscillator
- ONCY 42.83
- NIM 34.21
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued.